)
)
Initiator Pharma Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Initiator Pharma
Access all reports
Initiator Pharma A/S is a Danish clinical-stage biopharmaceutical company focusing on developing treatments for unmet medical needs related to the central and peripheral nervous systems. The company’s portfolio primarily targets disorders such as erectile dysfunction (ED) and neuropathic pain. Its clinical programs include drug candidates for both psychogenic and organic ED as well as a rare disease program for Trigeminal Neuralgia, a chronic pain condition. Initiator Pharma leverages its expertise in monoamine reuptake inhibitors, which increase key neurotransmitters like dopamine to treat various neurological conditions. The company is headquartered in Copenhagen, Denmark, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Ticker symbol
INIT
Country
🇸🇪 Sweden